title: A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.
authors.affiliation: College of Medicine, University of Arizona, Tucson, AZ, USA.
authors.forename: Lindsay
authors.initials: L
authors.lastname: LaPresto
authors.forename: Lee
authors.initials: L
authors.lastname: Cranmer
authors.forename: Lynne
authors.initials: L
authors.lastname: Morrison
authors.forename: Christof P
authors.initials: CP
authors.lastname: Erickson
authors.forename: Clara
authors.initials: C
authors.lastname: Curiel-Lewandrowski
mesh_terms: D017255:Acitretin / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D015552:Injections, Intralesional; D007636:Keratoacanthoma / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology; D009154:Mutation; D009362:Neoplasm Metastasis; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077484:Vemurafenib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D007641:Keratolytic Agents; D013449:Sulfonamides; D000077484:Vemurafenib; D048493:Proto-Oncogene Proteins B-raf; D017255:Acitretin; D005472:Fluorouracil
references.citation: N Engl J Med. 2012 Feb 23;366(8):707-14
references.pmid: 22356324
references.citation: J Am Acad Dermatol. 2011 Feb;64(2):413-22
references.pmid: 20334952
references.citation: N Engl J Med. 2012 Jan 19;366(3):207-15
references.pmid: 22256804
references.citation: N Engl J Med. 2012 Nov;367(18):1694-703
references.pmid: 23020132
references.citation: J Clin Oncol. 1995 Aug;13(8):1933-8
references.pmid: 7636533